Fosun Pharma says will buy Israel's Alma Lasers Ltd for $240 million

HONG KONG Sun Apr 28, 2013 4:46am EDT

Related Topics

HONG KONG (Reuters) - Shanghai Fosun Pharma (Group) Ltd (600196.SS) said on Sunday it would spend up to $240 million to acquire up to 96.6 percent of Israel-based Alma Lasers Ltd (ALMA.O), a manufacturer of lasers used in cosmetic surgery.

It is the first major buyout deal by Fosun Pharma since it listed on the Hong Kong Stock Exchange last October.

Fosun Pharma, a subsidiary of China's Fosun International Limited (0656.HK), said it would make the investment together with Pramerica-Fosun China Opportunity Fund, a US-dollar denominated investment fund owned by Fosun Group.

(Reporting by Lawrence White)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.